Monolithic Power Systems, Inc. (MPWR)
NASDAQ: MPWR · Real-Time Price · USD
797.51
-6.78 (-0.84%)
At close: Aug 11, 2025, 4:00 PM
798.31
+0.80 (0.10%)
After-hours: Aug 11, 2025, 6:54 PM EDT
G1 Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts that cover G1 Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $855.31, which forecasts a 7.25% increase in the stock price over the next year. The lowest target is $750 and the highest is $994.
Price Target: $855.31 (+7.25%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for G1 Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $785 → $825 | Strong Buy | Maintains | $785 → $825 | +3.45% | Aug 4, 2025 |
| Stifel | Stifel | Strong Buy Maintains $880 → $930 | Strong Buy | Maintains | $880 → $930 | +16.61% | Aug 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $730 → $750 | Hold | Maintains | $730 → $750 | -5.96% | Aug 1, 2025 |
| Raymond James | Raymond James | Buy Reiterates $720 → $875 | Buy | Reiterates | $720 → $875 | +9.72% | Aug 1, 2025 |
| Keybanc | Keybanc | Buy Maintains $940 → $950 | Buy | Maintains | $940 → $950 | +19.12% | Aug 1, 2025 |
Financial Forecast
Revenue This Year
2.71B
from 2.21B
Increased by 22.97%
Revenue Next Year
3.13B
from 2.71B
Increased by 15.18%
EPS This Year
17.31
from 36.59
Decreased by -52.70%
EPS Next Year
20.47
from 17.31
Increased by 18.30%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.8B | 3.4B | 3.9B | ||
| Avg | 2.7B | 3.1B | 3.6B | ||
| Low | 2.6B | 2.9B | 3.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 28.6% | 25.8% | 26.1% | ||
| Avg | 23.0% | 15.2% | 15.5% | ||
| Low | 16.5% | 7.4% | 1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.45 | 24.07 | 25.69 | ||
| Avg | 17.31 | 20.47 | 23.68 | ||
| Low | 16.37 | 18.72 | 21.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -49.6% | 39.1% | 25.5% | ||
| Avg | -52.7% | 18.3% | 15.6% | ||
| Low | -55.3% | 8.2% | 2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.